首页> 外国专利> METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING OBESITY-RELATED DISORDERS BY OPSIN 3 REGULATION OF HYPOTHALAMIC MELANOCORTIN RECEPTORS

METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING OBESITY-RELATED DISORDERS BY OPSIN 3 REGULATION OF HYPOTHALAMIC MELANOCORTIN RECEPTORS

机译:用于治疗或预防肥胖相关疾病的方法和组合物通过OPSIN 3调节下丘脑黑素素受体受体

摘要

Described herein are methods and compositions for the prevention or treatment of obesity and obesity-related disorders. The methods and compositions are based, inter alia, on the observations that OPN3 is the most highly expressed opsin in the hypothalamus, a key site for the regulation of energy homeostasis. Indeed, OPN3 expression was highest in regions associated with energy homeostasis, namely the paraventricular nucleus and arcuate nucleus of the hypothalamus. OPN3 was shown to interact and form a complex with MC3R and MC4R, and to modulate MC3R- and MC4R-mediated signaling in the hypothalamus. Accordingly, the methods involve the regulation of melanocortin receptors by down regulating opsin 3 (OPN3) protein expression, OPN3 gene expression, and/or OPN3 activation in the hypothalamus.
机译:本文描述的是用于预防或治疗肥胖和肥胖相关疾病的方法和组合物。方法和组合物是基于,尤其是观察结果,即OPN3是下丘脑中最高表达的Opsin,是用于调节能量稳态的关键部位。实际上,opn3表达在与能量稳态相关的区域中是最高的,即下丘脑的椎间盘核和弧形核。显示OPN3与MC3R和MC4R相互作用并形成复合物,并调节下丘脑中MC3R和MC4R介导的信号传导。因此,该方法涉及通过向下调节OPSIN 3(OPN3)蛋白表达,OPN3基因表达和/或OPN3活化在下丘脑中调节黑素旋基因受体。

著录项

  • 公开/公告号WO2021062124A3

    专利类型

  • 公开/公告日2021-05-14

    原文格式PDF

  • 申请/专利权人 BROWN UNIVERSITY;

    申请/专利号USUS2020/052676

  • 发明设计人 OANCEA ELENA;

    申请日2020-09-25

  • 分类号A61K48;C12N15/11;A61K38;C12N15;A61K38/46;C07H21/04;

  • 国家 US

  • 入库时间 2022-08-24 18:42:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号